AIM - AIM ImmunoTech Inc.
0.6908
-0.009 -1.332%
Share volume: 161,205
Last Updated: 03-04-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.44%
PREVIOUS CLOSE
CHG
CHG%
$0.70
-0.01
-0.01%
View ratios
| Fiscal Date | 12-31-2024 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|
| Fiscal Quarter | Q4 2024 | Q2 2025 | Q3 2025 | |
| Report Date | 03-27-2025 | 08-14-2025 | 11-17-2025 | |
| Assets | ||||
| Total Assets | 8.608 M | 4.129 M | 5.494 M | |
| Current Assets | 4.176 M | 1.025 M | 2.575 M | |
| Inventories | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 2.276 M | 359.000 K | 62.000 K | |
| Total Receivables | 0.000 | 0.000 | 0.000 | |
| Current Cash | 1.701 M | 476.000 K | 2.347 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 108.000 K | 89.000 K | 80.000 K | |
| Other Assets | 4.324 M | 3.015 M | 2.839 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||
| Total Liabilities and shareholders’ equity | 8.608 M | 4.129 M | 5.494 M | |
| Total liabilities | 9.930 M | 10.675 M | 11.571 M | |
| Total current liabilities | 9.535 M | 10.393 M | 4.043 M | |
| Accounts Payable | 6.383 M | 7.297 M | 1.252 M | |
| Other liabilities | 395.000 K | 282.000 K | 7.528 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 395.000 K | 282.000 K | 7.528 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | -1.322 M | -6.546 M | -6.077 M | |
| Common stock | 425.506 M | 426.781 M | 430.534 M | |
| Retained earnings | -426.828 M | -433.327 M | -436.611 M |